financetom
Business
financetom
/
Business
/
GPM Metals Appoints John Tait as CEO, Says Walker Gossan Exploration to be Delayed Until Q2 2025
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GPM Metals Appoints John Tait as CEO, Says Walker Gossan Exploration to be Delayed Until Q2 2025
Sep 29, 2024 4:30 AM

10:10 AM EDT, 09/23/2024 (MT Newswires) -- GPM Metals ( GPMTF ) appointed 25-year mining industry veteran John Tait as chief executive.

Tait, who assumes the role from Peter Walsh, was president of Southern Star Resources before the company was renamed Gold Eagle Mines and sold to Goldcorp in 2008 for $1.5 billion. Tait has also been an officer and director of several exploration companies throughout his career.

The company also said Dan Noone will transition from executive chairman to chairman of the board.

Exploration drilling at the Walker Gossan project in Australia's Northern Territory has also been deferred to the end of the wet season, or the second quarter of 2025, GPM said. The road accessing the property deteriorated significantly during an 8-year absence of exploration on the property and an extreme rainfall event in the early 2024 storm season caused unexpected damage to the access route. The road repair required to access the site restricted GPM's exploration goals prior to the start of the wet season.

Price: 0.08, Change: -0.01, Percent Change: -11.76

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lilly's Foundayo hits 1,390 prescriptions in debut week
Lilly's Foundayo hits 1,390 prescriptions in debut week
Apr 17, 2026
April 17 (Reuters) - Eli Lilly's ( LLY ) newly launched obesity pill was prescribed 1,390 times in the U.S. as of the week ended April 10, according to an analyst who cited IQVIA data. Novo Nordisk's oral Wegovy had hit 3,071 U.S. prescriptions in the first four days after its launch on January 5. ...
Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week
Lilly's obesity pill Foundayo gets 1,390 prescriptions in debut week
Apr 17, 2026
April 17 (Reuters) - Eli Lilly's ( LLY ) newly launched obesity pill was prescribed 1,390 times in the U.S. as of the week ended April 10, according to an analyst who cited IQVIA data. Novo Nordisk's oral Wegovy had hit 3,071 U.S. prescriptions in the first four days after its launch on January 5. Investors have been closely watching...
Bruker's Division Rolls Out MyGenius PRO Diagnostics System in Europe
Bruker's Division Rolls Out MyGenius PRO Diagnostics System in Europe
Apr 17, 2026
06:53 AM EDT, 04/17/2026 (MT Newswires) -- Bruker's ( BRKR ) Bruker Microbiology & Infection Diagnostics division said Friday it has rolled out molecular diagnostics system MyGenius PRO in Europe. The new diagnostics system is based on polymerase chain reaction, developed to diagnose infectious diseases, according to the division. Bruker Microbiology said the MyGenius PRO system automates the complete workflow...
Market Chatter: Silgan's Bid to Acquire Gerresheimer Rejected
Market Chatter: Silgan's Bid to Acquire Gerresheimer Rejected
Apr 17, 2026
06:54 AM EDT, 04/17/2026 (MT Newswires) -- Silgan's ( SLGN ) bid to take over German medical packaging maker Gerresheimer has been rejected, Reuters reported Friday, citing sources familiar with the matter. Talks between the two companies have concluded, the sources reportedly said. Silgan ( SLGN ) made a non-binding offer of 41 euros ($48.36) per share, Reuters previously reported....
Copyright 2023-2026 - www.financetom.com All Rights Reserved